Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U A Walker

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Annals of the Rheumatic Diseases|January 20, 2007
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseU A Walker, A Tyndall, L Czirják, et al.
HIV Medicine|November 23, 2011
Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stressA C Ross, T Leong, A Avery, et al.
Vaccine|January 9, 2020
Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individualsJ Burkhard, A Ciurea, C Gabay, et al.
Annals of the Rheumatic Diseases|July 26, 2008
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cellsJ H W Distler, Y Allanore, J Avouac, et al.
Zeitschrift Fur Rheumatologie|March 26, 2015
[Common German language nomenclature for systemic sclerosis]M Aringer, U Müller-Ladner, H Burkhardt, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupJ Avouac, J Fransen, U A Walker, et al.
Arthritis Research & Therapy|January 26, 2019
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) surveyJ Blagojevic, S Bellando-Randone, G Abignano, et al.
Clinical Rheumatology|May 22, 2019
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher studyJelena Blagojevic, G Abignano, J Avouac, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
Scandinavian Journal of Rheumatology|October 10, 2017
There is a need for new systemic sclerosis subset criteria. A content analytic approachS R Johnson, M L Soowamber, J Fransen, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Annals of the Rheumatic Diseases|January 20, 2007
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseU A Walker, A Tyndall, L Czirják, et al.
HIV Medicine|November 23, 2011
Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stressA C Ross, T Leong, A Avery, et al.
Vaccine|January 9, 2020
Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individualsJ Burkhard, A Ciurea, C Gabay, et al.
Annals of the Rheumatic Diseases|July 26, 2008
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cellsJ H W Distler, Y Allanore, J Avouac, et al.
Zeitschrift Fur Rheumatologie|March 26, 2015
[Common German language nomenclature for systemic sclerosis]M Aringer, U Müller-Ladner, H Burkhardt, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupJ Avouac, J Fransen, U A Walker, et al.
Arthritis Research & Therapy|January 26, 2019
Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) surveyJ Blagojevic, S Bellando-Randone, G Abignano, et al.
Clinical Rheumatology|May 22, 2019
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher studyJelena Blagojevic, G Abignano, J Avouac, et al.
Annals of the Rheumatic Diseases|March 13, 2009
Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosisY Allanore, C Meune, M C Vonk, et al.
Scandinavian Journal of Rheumatology|October 10, 2017
There is a need for new systemic sclerosis subset criteria. A content analytic approachS R Johnson, M L Soowamber, J Fransen, et al.
Pageof 6